Cargando…
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients
SIMPLE SUMMARY: It is important to take into account a patient’s quality-of-life after surgery, especially after introducing a new surgical device. The aim of this study was to determine whether the use of the PlasmaJet Surgical device during surgery has an effect on the quality-of-life of patients...
Autores principales: | Nieuwenhuyzen-de Boer, Gatske M., Aamran, Hanane, van den Berg, Caroline B., Willemsen, Sten, Piek, Jurgen M. J., Reesink-Peters, Nathalie, Maliepaard, Marianne, van Doorn, Helena C., Polinder, Suzanne, van Beekhuizen, Heleen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416900/ https://www.ncbi.nlm.nih.gov/pubmed/37568763 http://dx.doi.org/10.3390/cancers15153947 |
Ejemplares similares
-
Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review
por: Nieuwenhuyzen-de Boer, Gatske M., et al.
Publicado: (2019) -
ASO Author Reflections: The PlasmaJet(®) Device Contributes to an Increase in the Number of Complete Cytoreductive Surgeries for Ovarian Cancer Patients
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2022) -
Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review
por: Brons, Puck E., et al.
Publicado: (2022) -
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2022) -
Factors Predicting 30-Day Grade IIIa–V Clavien–Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study
por: Kengsakul, Malika, et al.
Publicado: (2022)